Quintiles exec: Reduce clinical trial timelines to speed up drug, vaccine development
Editor’s note: In the midst of the deadly Ebola outbreak and the rushing to trial of experimental treatments such as one developed by Durham-based Chimerix, Durham-based Quintiles, the world’s largest life sciences services company, is calling for faster drug and vaccine development. In a 21st Century Cures Initiative discussion hosted by N.C. Rep. Renee Ellmers on Thursday in Research Triangle Park, the head of the Phase 1 Clinical Research Division at Quintiles, said Phase 1 trial “timelines” should be reduced by “addressing inefficiencies and redundancies.” Quintiles has helped develop and commercialize all of the world’s top 100 selling drugs...
Read More
